AAAAAA

   
Results: 1-25 | 26-50 | 51-71
Results: 1-25/71
HERG K+ channels: friend and foe
Authors: Vandenberg, JI Walker, BD Campbell, TJ
Citation: Ji. Vandenberg et al., HERG K+ channels: friend and foe, TRENDS PHAR, 22(5), 2001, pp. 240-246
Immune control of HIV: the obstacles of HLA and viral diversity
Authors: Walker, BD Korber, BT
Citation: Bd. Walker et Bt. Korber, Immune control of HIV: the obstacles of HLA and viral diversity, NAT IMMUNOL, 2(6), 2001, pp. 473-475
Less is more? STI in acute and chronic HIV-1 infection
Authors: Altfeld, M Walker, BD
Citation: M. Altfeld et Bd. Walker, Less is more? STI in acute and chronic HIV-1 infection, NAT MED, 7(8), 2001, pp. 881-884
Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody
Authors: Walensky, RP Rosenberg, ES Ferraro, MJ Losina, E Walker, BD Freedberg, KA
Citation: Rp. Walensky et al., Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibody, CLIN INF D, 33(4), 2001, pp. 570-572
Human immunodeficieny virus pathogenesis and prospects for immune control in patients with established infection
Authors: Cohen, DE Walker, BD
Citation: De. Cohen et Bd. Walker, Human immunodeficieny virus pathogenesis and prospects for immune control in patients with established infection, CLIN INF D, 32(12), 2001, pp. 1756-1768
Clozapine and sudden death
Authors: Tie, H Walker, BD Singleton, CB Bursill, JA Wyse, KR Campbell, TJ Valenzuela, SM Breit, SN
Citation: H. Tie et al., Clozapine and sudden death, J CL PSYCH, 21(6), 2001, pp. 630-632
Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation
Authors: Goulder, PJR Pasquier, C Holmes, EC Liang, B Tang, YH Izopet, J Saune, K Rosenberg, ES Burchett, SK McIntosh, K Barnardo, M Bunce, M Walker, BD Brander, C Phillips, RE
Citation: Pjr. Goulder et al., Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation, IMMUNOL LET, 79(1-2), 2001, pp. 109-116
Medical progress: Hepatitis C virus infection.
Authors: Lauer, GM Walker, BD
Citation: Gm. Lauer et Bd. Walker, Medical progress: Hepatitis C virus infection., N ENG J MED, 345(1), 2001, pp. 41-52
Evolution and transmission of stable CTL escape mutations in HIV infection
Authors: Goulder, PJR Brander, C Tang, YH Tremblay, C Colbert, RA Addo, MM Rosenberg, ES Nguyen, T Allen, R Trocha, A Altfeld, M He, SQ Bunce, M Funkhouser, R Pelton, SI Burchett, SK McIntosh, K Korber, BTM Walker, BD
Citation: Pjr. Goulder et al., Evolution and transmission of stable CTL escape mutations in HIV infection, NATURE, 412(6844), 2001, pp. 334-338
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity
Authors: Flores-Villanueva, PO Yunis, EJ Delgado, JC Vittinghoff, E Buchbinder, S Leung, JY Uglialoro, AM Clavijo, OP Rosenberg, ES Kalams, SA Braun, JD Boswell, SL Walker, BD Goldfeld, AE
Citation: Po. Flores-villanueva et al., Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity, P NAS US, 98(9), 2001, pp. 5140-5145
The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals
Authors: Addo, MM Altfeld, M Rosenberg, ES Eldridge, RL Philips, MN Habeeb, K Khatri, A Brander, C Robbins, GK Mazzara, GP Goulder, PJR Walker, BD
Citation: Mm. Addo et al., The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals, P NAS US, 98(4), 2001, pp. 1781-1786
Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV
Authors: Wong, DKH Dudley, DD Dohrenwend, PB Lauer, GM Chung, RT Thomas, DL Walker, BD
Citation: Dkh. Wong et al., Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV, J VIROLOGY, 75(3), 2001, pp. 1229-1235
Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif
Authors: Altfeld, MA Livingston, B Reshamwala, N Nguyen, PT Addo, MM Shea, A Newman, M Fikes, J Sidney, J Wentworth, P Chesnut, R Eldridge, RL Rosenberg, ES Robbins, GK Brander, C Sax, PE Boswell, S Flynn, T Buchbinder, S Goulder, PJR Walker, BD Sette, A Kalams, SA
Citation: Ma. Altfeld et al., Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif, J VIROLOGY, 75(3), 2001, pp. 1301-1311
Rapid definition of five novel HLA-A3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by Elispot and intracellular cytokine staining assays
Authors: Goulder, PJR Addo, MM Altfeld, MA Rosenberg, ES Tang, YH Govender, U Mngqundaniso, N Annamalai, K Vogel, TU Hammond, M Bunce, M Coovadia, HM Walker, BD
Citation: Pjr. Goulder et al., Rapid definition of five novel HLA-A3002-restricted human immunodeficiency virus-specific cytotoxic T-lymphocyte epitopes by Elispot and intracellular cytokine staining assays, J VIROLOGY, 75(3), 2001, pp. 1339-1347
Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection
Authors: Montefiori, DC Hill, TS Vo, HTT Walker, BD Rosenberg, ES
Citation: Dc. Montefiori et al., Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infection, J VIROLOGY, 75(21), 2001, pp. 10200-10207
Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones
Authors: Norris, PJ Sumaroka, M Brander, C Moffett, HF Boswell, SL Nguyen, T Sykulev, Y Walker, BD Rosenberg, ES
Citation: Pj. Norris et al., Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones, J VIROLOGY, 75(20), 2001, pp. 9771-9779
Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-Infected persons and HIV-1-Specific cytotoxic T lymphocytes is not mediated by beta-chemokines
Authors: Geiben-Lynn, R Kursar, M Brown, NV Kerr, EL Luster, AD Walker, BD
Citation: R. Geiben-lynn et al., Noncytolytic inhibition of X4 virus by bulk CD8(+) cells from human immunodeficiency virus type 1 (HIV-1)-Infected persons and HIV-1-Specific cytotoxic T lymphocytes is not mediated by beta-chemokines, J VIROLOGY, 75(17), 2001, pp. 8306-8316
Relative dominance of epitope-specific cytotoxic T-lymphocyte responses inhuman immunodeficiency virus type 1-infected persons with shared HLA alleles
Authors: Day, CL Shea, AK Altfeld, MA Olson, DP Buchbinder, SP Hecht, FM Rosenberg, ES Walker, BD Kalams, SA
Citation: Cl. Day et al., Relative dominance of epitope-specific cytotoxic T-lymphocyte responses inhuman immunodeficiency virus type 1-infected persons with shared HLA alleles, J VIROLOGY, 75(14), 2001, pp. 6279-6291
Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi's sarcoma-associated herpesvirus kaposin protein
Authors: Brander, C O'Connor, P Suscovich, T Jones, NG Lee, Y Kedes, D Ganem, D Martin, J Osmond, D Southwood, S Sette, A Walker, BD Scadden, DT
Citation: C. Brander et al., Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi's sarcoma-associated herpesvirus kaposin protein, J INFEC DIS, 184(2), 2001, pp. 119-126
Vpr is preferentially targeted by CTL during HIV-1 infection
Authors: Altfeld, M Addo, MM Eldridge, RL Yu, XG Thomas, S Khatri, A Strick, D Phillips, MN Cohen, GB Islam, SA Kalams, SA Brander, C Goulder, PJR Rosenberg, ES Walker, BD
Citation: M. Altfeld et al., Vpr is preferentially targeted by CTL during HIV-1 infection, J IMMUNOL, 167(5), 2001, pp. 2743-2752
Inhibition of human NK cell-mediated cytotoxicity by exposure to ammonium chloride
Authors: Brander, C Matter-Reissmann, UB Jones, NG Walker, BD Sachs, DH Seebach, JD
Citation: C. Brander et al., Inhibition of human NK cell-mediated cytotoxicity by exposure to ammonium chloride, J IMMUNOL M, 252(1-2), 2001, pp. 1-14
Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
Authors: Altfeld, M Rosenberg, ES Shankarappa, R Mukherjee, JS Hecht, FM Eldridge, RL Addo, MM Poon, SH Phillips, MN Robbins, GK Sax, PE Boswell, S Kahn, JO Brander, C Goulder, PJR Levy, JA Mullins, JI Walker, BD
Citation: M. Altfeld et al., Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection, J EXP MED, 193(2), 2001, pp. 169-180
Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection
Authors: Goulder, PJR Altfeld, MA Rosenberg, ES Nguyen, T Tang, YH Eldridge, RL Addo, MM He, SQ Mukherjee, JS Phillips, MN Bunce, M Kalams, SA Sekaly, RP Walker, BD Brander, C
Citation: Pjr. Goulder et al., Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection, J EXP MED, 193(2), 2001, pp. 181-193
HIV versus the immune system: another apparent victory for the virus
Authors: Letvin, NL Walker, BD
Citation: Nl. Letvin et Bd. Walker, HIV versus the immune system: another apparent victory for the virus, J CLIN INV, 107(3), 2001, pp. 273-275
Characterization of the HIV-1-specific T-helper cell-response
Authors: Walker, BD
Citation: Bd. Walker, Characterization of the HIV-1-specific T-helper cell-response, INFEC DIS S, 2001, pp. 237-247
Risultati: 1-25 | 26-50 | 51-71